About
Relay Therapeutics is a clinical-stage precision medicines company that transforms drug discovery by integrating computational and experimental technologies to understand protein motion. Their proprietary Dynamo Platform visualizes how proteins move, enabling precise drug design for targets previously considered intractable by conventional discovery methods. The company initially focuses on developing therapeutics in oncology and genetic diseases.
Tags
Performance
Company Timeline
No timeline data for this period
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Relay Therapeutics do?
Relay Therapeutics is a clinical-stage precision medicines company that transforms drug discovery by integrating computational and experimental technologies to understand protein motion. Their proprietary Dynamo Platform visualizes how proteins move, enabling precise drug design for targets previously considered intractable by conventional discovery methods. The company initially focuses on developing therapeutics in oncology and genetic diseases.
How much funding has Relay Therapeutics raised?
Relay Therapeutics has raised a total of $550M in funding. The most recent round on record is Private Placement.
When was Relay Therapeutics founded?
Relay Therapeutics was founded in 2015.